Sulfuric Acid

Sulfuric Acid

SCHEMBL5532907

C[C@]12C=CC(=O)CC1CC[C@@H]1[C@H]2CC[C@]2(C)C(=O)CC[C@@H]12.O=S(=O)(O)O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 6/20 0.50
AKR1B10 O60218 2/20 0.50
AKR1B1 P15121 2/20 0.50
OR51E2 Q9H255 1/20 0.50
LMNA P02545 5/20 0.48
GPBAR1 Q8TDU6 4/20 0.48
CYP3A4 P08684 4/20 0.48
SHBG P04278 4/20 0.48
SERPINA6 P08185 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
MAPK1 P28482 3/20 0.48
HSD17B3 P37058 3/20 0.48
PMP22 Q01453 3/20 0.48
G6PD P11413 2/20 0.48
CYP2D6 P10635 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
CYP2C19 P33261 1/20 0.48
SRD5A2 P31213 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL27824496 0.94 CYP19A1 (0.53) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL9512557 0.94 CYP19A1 (0.55) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL1287861 0.94 CYP19A1 (0.55) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL2186022 0.94 CYP19A1 (0.55) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL1287860 0.94 CYP19A1 (0.55) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL12857149 0.94 CYP19A1 (0.55) CYP19A1AKR1B10AKR1B1OR51E2LMNA
Water SCHEMBL27940020 0.93 CYP19A1 (0.54) CYP19A1AKR1B10AKR1B1OR51E2LMNA
Acetic Acid SCHEMBL31729653 0.91 CYP19A1 (0.50) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL29757161 0.82 GRIN1 (0.43) CYP19A1AKR1B10AKR1B1OR51E2LMNA
SCHEMBL27741165 0.82 CYP19A1 (0.49) CYP19A1AKR1B10AKR1B1OR51E2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007103162-A2 STRUCTURE BASED DRUG DESIGN OF STEROIDOGENESIS INHIBITORS SAMARITAN PHARMACEUTICALS, INC. (US) 2007-09-13 WO claimed
WO-2007103162-A2 STRUCTURE BASED DRUG DESIGN OF STEROIDOGENESIS INHIBITORS SAMARITAN PHARMACEUTICALS, INC. (US) 2007-09-13 WO disclosed